462 related articles for article (PubMed ID: 21753179)
1. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
Lucas RM; Ponsonby AL; Dear K; Valery P; Pender MP; Burrows JM; Burrows SR; Chapman C; Coulthard A; Dwyer DE; Dwyer T; Kilpatrick T; Lay ML; McMichael AJ; Taylor BV; van der Mei IA; Williams D
Neurology; 2011 Jul; 77(4):371-9. PubMed ID: 21753179
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
[TBL] [Abstract][Full Text] [Related]
3. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
[TBL] [Abstract][Full Text] [Related]
5. Risk of a first clinical diagnosis of central nervous system demyelination in relation to human herpesviruses in the context of Epstein-Barr virus.
Lucas RM; Lay MJ; Grant J; Cherbuin N; Toi CS; Dear K; Taylor BV; Dwyer DE; ; Ponsonby AL
Eur J Neurol; 2023 Sep; 30(9):2752-2760. PubMed ID: 37306550
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis and Epstein-Barr virus.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
[TBL] [Abstract][Full Text] [Related]
7. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.
Thomas OG; Haigh TA; Croom-Carter D; Leese A; Van Wijck Y; Douglas MR; Rickinson A; Brooks JM; Taylor GS
PLoS Pathog; 2024 Jun; 20(6):e1012177. PubMed ID: 38843296
[TBL] [Abstract][Full Text] [Related]
8. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
[TBL] [Abstract][Full Text] [Related]
9. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
Strautins K; Tschochner M; James I; Choo L; Dunn DS; Pedrini M; Kermode A; Carroll W; Nolan D
Mult Scler; 2014 Mar; 20(3):286-94. PubMed ID: 23886832
[TBL] [Abstract][Full Text] [Related]
10. Smoking and Epstein-Barr virus infection in multiple sclerosis development.
Hedström AK; Huang J; Brenner N; Butt J; Hillert J; Waterboer T; Kockum I; Olsson T; Alfredsson L
Sci Rep; 2020 Jul; 10(1):10960. PubMed ID: 32620875
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
Salzer J; Nyström M; Hallmans G; Stenlund H; Wadell G; Sundström P
Mult Scler; 2013 Oct; 19(12):1587-91. PubMed ID: 23549431
[TBL] [Abstract][Full Text] [Related]
12. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
Rubicz R; Yolken R; Drigalenko E; Carless MA; Dyer TD; Bauman L; Melton PE; Kent JW; Harley JB; Curran JE; Johnson MP; Cole SA; Almasy L; Moses EK; Dhurandhar NV; Kraig E; Blangero J; Leach CT; Göring HH
PLoS Genet; 2013; 9(1):e1003147. PubMed ID: 23326239
[TBL] [Abstract][Full Text] [Related]
13. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
Munger KL; Levin LI; O'Reilly EJ; Falk KI; Ascherio A
Mult Scler; 2011 Oct; 17(10):1185-93. PubMed ID: 21685232
[TBL] [Abstract][Full Text] [Related]
14. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.
De Jager PL; Simon KC; Munger KL; Rioux JD; Hafler DA; Ascherio A
Neurology; 2008 Mar; 70(13 Pt 2):1113-8. PubMed ID: 18272866
[TBL] [Abstract][Full Text] [Related]
15. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis.
Wagner HJ; Munger KL; Ascherio A
Eur J Neurol; 2004 Dec; 11(12):833-4. PubMed ID: 15667414
[TBL] [Abstract][Full Text] [Related]
16. Epstein-barr virus and multiple sclerosis risk in the finnish maternity cohort.
Munger KL; Hongell K; Cortese M; Åivo J; Soilu-Hänninen M; Surcel HM; Ascherio A
Ann Neurol; 2019 Sep; 86(3):436-442. PubMed ID: 31226219
[TBL] [Abstract][Full Text] [Related]
17. Exposure to infant siblings during early life and risk of multiple sclerosis.
Ponsonby AL; van der Mei I; Dwyer T; Blizzard L; Taylor B; Kemp A; Simmons R; Kilpatrick T
JAMA; 2005 Jan; 293(4):463-9. PubMed ID: 15671431
[TBL] [Abstract][Full Text] [Related]
18. Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis.
Almohmeed YH; Avenell A; Aucott L; Vickers MA
PLoS One; 2013; 8(4):e61110. PubMed ID: 23585874
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection.
Harada S; Kamata Y; Ishii Y; Eda H; Kitamura R; Obayashi M; Ito S; Ban F; Kuranari J; Nakajima H; Kuze T; Hayashi M; Okabe N; Senpuku H; Miyasaka N; Nakamura Y; Kanegane H; Yanagi K
Clin Diagn Lab Immunol; 2004 Jan; 11(1):123-30. PubMed ID: 14715558
[TBL] [Abstract][Full Text] [Related]
20. Population attributable fractions and joint effects of key risk factors for multiple sclerosis.
van der Mei I; Lucas RM; Taylor BV; Valery PC; Dwyer T; Kilpatrick TJ; Pender MP; Williams D; Chapman C; Otahal P; Ponsonby AL
Mult Scler; 2016 Apr; 22(4):461-9. PubMed ID: 26199349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
